Paeoniflorin Combination of Hepatoprotective Drugs Versus Hepatoprotective Drugs Only for Auto-immune Hepatitis

Exclusion Criteria

• •The presence of hepatitis A, B, C, D, or E virus infection;
• •Patients with presence of liver cirrhosis or portal hypertension;
• •Patients with presence of fulminant liver failure;
• •Primary sclerosing cholangitis, non-alcoholic steatohepatitis, drug induced liver disease or Wilson disease confirmed by liver biopsy;
• •Pregnant and breeding women;
• •Severe disorders of other vital organs, such as severe heart failure, cancer;
• •Parenteral administration of blood or blood products within 6 months before screening;
• •Recent treatment with drugs having known liver toxicity;
• •Taken part in other clinic trials within 6 months before screening.